Seine-Saint-Denis

Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European Union

Retrieved on: 
Monday, December 11, 2023

The marketing authorisation (MA) for Elucirem™ (Gadopiclenol) was granted to Guerbet by the European Commission based on the positive opinion of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) dated 12 October 2023.

Key Points: 
  • The marketing authorisation (MA) for Elucirem™ (Gadopiclenol) was granted to Guerbet by the European Commission based on the positive opinion of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) dated 12 October 2023.
  • It will be marketed by Guerbet in the European Union in the following forms: vials and prefilled syringes.
  • "After its approval by the FDA for the American market, the European marketing authorisation for Elucirem™ reinforces our strategic perspective: combining medical innovation and environmental commitment.
  • This authorisation is ground-breaking for Medical Imaging in Europe," concludes David Hale, Guerbet CEO.

France Elevator and Escalator Market Report 2022-2027 - Grand Paris Project and the 2024 Olympic Games in Paris are Expected to Propel the Elevator Market Forward - ResearchAndMarkets.com

Retrieved on: 
Friday, August 5, 2022

The increasing number of the aging population has paved the path for tremendous expansion in the elevator and escalator industry.

Key Points: 
  • The increasing number of the aging population has paved the path for tremendous expansion in the elevator and escalator industry.
  • The Grand Paris Project and the 2024 Olympic Games in Paris are expected to propel the elevator market forward.
  • The demand for elevator security in France and other European countries is a primary driver of the elevator market.
  • The key players in France's Elevator & Escalator market are KONE, Otis, Hyundai Elevator TKE, Schindler, Mitsubishi Electric, Hitachi, Toshiba, Fujitec, and Kohler.

Ambulatory EHR Market Worth $6.74 Billion by 2028 - Exclusive Report by Meticulous Research

Retrieved on: 
Thursday, March 3, 2022

Based on deployment mode, the ambulatory EHR market is segmented into the cloud/web-based ambulatory EHR and on-premise ambulatory EHR segments.

Key Points: 
  • Based on deployment mode, the ambulatory EHR market is segmented into the cloud/web-based ambulatory EHR and on-premise ambulatory EHR segments.
  • Based on type, the ambulatory EHR market is segmented into modular ambulatory EHR and all-in-one ambulatory EHR.
  • In 2021, the all-in-one ambulatory EHR segment accounted for the larger share of the overall ambulatory EHR market.
  • Quick Buy Ambulatory EHR Market Research Report: https://www.meticulousresearch.com/Checkout/96833537
    Based on practice size, the ambulatory EHR market is segmented into large practices, small-to-medium-sized practices, and solo practices.

Ambulatory EHR Market Worth $6.74 Billion by 2028 - Exclusive Report by Meticulous Research

Retrieved on: 
Thursday, March 3, 2022

Based on deployment mode, the ambulatory EHR market is segmented into the cloud/web-based ambulatory EHR and on-premise ambulatory EHR segments.

Key Points: 
  • Based on deployment mode, the ambulatory EHR market is segmented into the cloud/web-based ambulatory EHR and on-premise ambulatory EHR segments.
  • Based on type, the ambulatory EHR market is segmented into modular ambulatory EHR and all-in-one ambulatory EHR.
  • In 2021, the all-in-one ambulatory EHR segment accounted for the larger share of the overall ambulatory EHR market.
  • Quick Buy Ambulatory EHR Market Research Report: https://www.meticulousresearch.com/Checkout/96833537
    Based on practice size, the ambulatory EHR market is segmented into large practices, small-to-medium-sized practices, and solo practices.